The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive
Objective: To examine the rate of ovulatory disruption when intramuscular depot medroxyprogesterone acetate (DMPA) is administered across graded stages of dominant follicle development. Study design: We assigned enrolled participants to one of three preassigned dominant follicle size groups: 12-14 m...
Saved in:
Main Authors: | Robyn Schickler (Author), Diana Crabtree-Sokol (Author), Jasmine Patel (Author), Nicole Bender (Author), Anita L. Nelson (Author), Brian T. Nguyen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Risk of Infection Human Papilloma Virus Infection in Acceptors of Depot Medroxyprogesterone Acetate Contraceptions
by: Baharuddin Aras, et al.
Published: (2018) -
Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017) -
Effects of Depot Medroxyprogesterone Acetate Intramuscular Injection, Copper Intrauterine Device and Levonorgestrel Implant Contraception on Estradiol Levels: An Ancillary Study of the ECHO Randomized Trial
by: Rebecca Ryan, et al.
Published: (2022) -
New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes
by: Amanda Stang, et al.
Published: (2000) -
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022)